Safe Injection Equipment Industry Consultation 28 th 29 th March 2017 Overview of UNICEF procurement of Safe Injection Equipment Rob Matthews, HTC
Objective of Session Provide an overview of UNICEFs engagement in Safe Injection Equipment (SIE) procurement Strengths and Challenges faced Share Outcomes from Activities undertaken
UNICEF has a key role in Immunization procurement, including Vaccines, Safe Injection Equipment and Cold Chain Equipment; procuring immunization supplies on behalf of around 100 countries annually 2016 Safe Injection Supplies: US$ 30.9 million 740 Million Pieces doses 1427 Transactions Source UNICEF Supply Division 532 Shipments Immunization Supplies Vaccines Safe Injection Equipment Cold Chain Equipment Countries UNICEF procures Injection devices on behalf of: Full schedule Partial schedule Source: UNIICEF Supply Division
Safe Injection Equipment UNICEF Product Scope Commodity Overview 5 Commodity Groupings Programme Focus Areas Usage/ Application Product Strategic Profiling Auto-Disable (AD) Syringes Immunization Injection for Immunization 26 Standard Stock Materials Safety Boxes Immunization & Curative Safe Disposal of Syringes Disposable Syringes Re-Use Prevention (RUP) Syringes Immunization & Curative Immunization & Curative Needles Curative Health Kits Reconstitution of Vaccines; As part of Health Kits All considered Strategic due to their role in Immunization and Emergency response and UNICEF s role in the market Primary Demand Immunization (>90%); Curative Demand principally for Kits Contributing Directly to 2 MTSP Result Areas Result 1: Survival during delivery and the neonatal period and living free from preventable diseases and disability; Result 2: Protected from HIV infection and free from AIDS.
Immunization Devices UNICEF Product Scope
Immunization Devices UNICEF Product Scope
Value of UNICEF SIE procurement 2005-2016
UNICEF SIE Procurement Values and Volumes for products procured under LTA
Product Diversity within the immunization context Profile Vaccines Injection Devices Product profile Biological Plastics Quality Assurance Production Lead time Storage requirements WHO PQ, GMP, Batch Release 6-24 months 2-4 weeks Temp controlled (Cold Chain) WHO PQS, UNICEF Tech. Assessment, Field Test, Inspection Dry Stores Supply Base Restricted Healthy (Ability to respond dependent on forecast accuracy) Shelf life 2 years 5 Years Shipment Mode Air Sea
Product Diversity within the immunization context $1,7 Billion, 2,8 Billion doses of vaccines cannot be used without the associated safe injection equipment.(rota, OCV, OPV excluded)
Supply and Demand Mapping of AD Syringes; Safety Boxes; Reconstitution Syringes 10% 2% 13% 6% LTA Supply Base AD Syringes Reconstitution Syringes AD and Reconstitution Syringes Safety Boxes AD and Recon Syringes and Safety Boxes Demand Profile by Region 40% XX % Shown as a Percentage of total UNICEF LTA demand by UNICEF Region 1% 28% Source: UNICEF SD LTA PO quantities by Region 2012-2016
AD Syringe Volumes and WAP 2005-2016
0,5ml AD Syringe Historic Awarded Price Range 2005-2017
Safety Box Volumes and WAP 2005-2016
Disposable and RUP Volumes and WAP 2005-2016
Needles Volumes and WAP 2005-2016
Influencing Markets Scale up pathway: 0.5ml AD syringes COLLABORATION: SIGN EST. 1999 POLICY GUIDANCE: Joint Policy on Safe Injection (1999): By the end of 2003, all countries should use only auto-disable syringes for immunization PERFORMANCE STANDARDS: 2000: AD performance standard and listed on WHO PIS 2004:WHO PQS and AD listed under E08 category MARKET GUIDANCE: 2005: UNICEF Expressed preference for more early AD feature activation 2009: All awards met the UNICEF preference INDIA Procurement: Through UNICEF in 2006 only PRICE TRANSPARENCY : UNICEF price transparency is launched in 2011 and facilitates downward pressure on prices COMPETITION, SUPPLY: 2006-2010: Increased global competition; 2014: Healthy Market achieved EFFICIENCY DRIVES & NEW CONTRACTING MODALITY: 2015: Single RFP covering all Safe Injection Equipment; 2016/17: >40% of Awards for bundled supply of AD s and safety boxes - for increased delivery efficiency DONOR SUPPORT: Measles & MNT Campaign Scale up (2000); GAVI Support INS & NVS from 2001 provided the funding security to bring the market to scale CONSOLIDATION OF DEMAND: New Policy & Standards and Funding through UNICEF consolidated demand in a previously fragmented market. First multi-year supply arrangements in 2001
Service Delivery: ensuring focus on the whole supply chain, engaging all Stakeholders
Service Delivery The Dream The Reality Opportunity for Efficiencies, expansion, refinement Key Success factor, critical management and monitoring
The ordering process by design creates an increasing number of activities The Dream The Reality
Service Delivery Supply Management Use of Allocation Tables for Supply Management Following up on the forecasts, order placement Generating monthly supplier reports Capturing data for analysis
Service Delivery Supply Management Reporting
Service delivery Opportunities for further improvement Forecasting Annual Forecast Exercise with over 100 Countries Reviewed with Partners, against prior forecast accuracy and order profiling 1 Absolute Guarantee: Forecasts will change Key to provide regular updates to the forecast to manage production planning and timely delivery
Performance Monitoring On Time Arrival Jan Oct 2016
Thank You! Thank you!